Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523679012 | Product containing certolizumab pegol (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3713866015 | Certolizumab pegol-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Certolizumab pegol-containing product | Is a | Tumour necrosis factor alpha inhibitor-containing product | true | Inferred relationship | Some | ||
| Certolizumab pegol-containing product | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Some | ||
| Certolizumab pegol-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Certolizumab pegol-containing product | Has active ingredient | Certolizumab pegol | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Certolizumab pegol only product | Is a | True | Certolizumab pegol-containing product | Inferred relationship | Some | |
| Certolizumab pegol-containing product in parenteral dose form | Is a | True | Certolizumab pegol-containing product | Inferred relationship | Some | |
| Certolizumab pegol 200mg powder for injection solution vial + diluent | Is a | False | Certolizumab pegol-containing product | Inferred relationship | Some | |
| Certolizumab pegol 200 mg powder for solution for injection vial | Is a | False | Certolizumab pegol-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR